Table 2.
Adverse events by types and grades.
| Incidence | Grade I, II | Grade III | Grade IV |
|---|---|---|---|
| Hematologic | |||
| Neutropenia | 1 (5.6%) | 6 (33.3%) | 3 (16.7%) |
| Anemia | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Non-hematologic | |||
| Generalized weakness | 5 (27.8%) | 0 (0%) | 0 (0%) |
| Vomiting | 2 (11.1%) | 0% (0) | 0 (0%) |
| Nausea | 1 (5.6%) | 0 (0%) | 0 (0%) |
| Ascites | 0 (0%) | 2 (11.1%) | 0 (0%) |
| Oral mucositis | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Bile duct stenosis | 0 (0%) | 0 (0%) | 1 (5.6%) |
| Infection | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Fever | 1 (5.6%) | 0 (0%) | 0 (0%) |
| Aspiration | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Hypoxia | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Thromboembolic event | 1 (5.6%) | 0 (0%) | 0 (0%) |
| Hypokalemia | 1 (5.6%) | 0 (0%) | 0 (0%) |
| Spinal fracture | 0 (0%) | 1 (5.6%) | 0 (0%) |
| Dysuria | 1 (5.6%) | 0 (0%) | 0 (0%) |
| Injection site reaction | 1 (5.6%) | 0 (0%) | 0 (0%) |